• Explore /
  • Poster
  • / Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study.

Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study.

Abstract Poster

Authors

null

Serge Leyvraz

Centre Pluridisciplinaire d'Oncologie, Lausanne, Switzerland

Serge Leyvraz , Stefan Suciu , Sophie Piperno-Neumann , Jean-Francois Baurain , Marcin Zdzienicki , Alessandro Testori , Ernest Marshall , Max E. Scheulen , Thomas Jouary , Sylvie Negrier , Jan Baptist Vermorken , Eckhart Kaempgen , Xavier Durando , Dirk Schadendorf , Ravichandra Karra Gurunath , Larissa Polders , Gaetan De Schaetzen , Simon Vanderschaeghe , Marie-Pierre Gauthier , Ulrich Keilholz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Melanoma/Skin Cancers

Track

Melanoma/Skin Cancers

Sub Track

Melanoma

Clinical Trial Registration Number

NCT00110123

Citation

J Clin Oncol 30, 2012 (suppl; abstr 8532)

DOI

10.1200/jco.2012.30.15_suppl.8532

Abstract #

8532

Poster Bd #

21

Abstract Disclosures

Similar Posters

First Author: Roger Olofsson Bagge

First Author: Roger Olofsson Bagge

First Author: Yusuke Iizuka

First Author: Rino S Seedor